Combining the PAK inhibitor IPA3 with FTI 277 exerts a potent antiproliferative action in melanoma, lung and colon cell lines The large number of possible group I PAK activators in technical support proliferating cells, many of which remain unknown, makes it difficult to identify proteins that might ac tivate group I PAKs in the nuclei of different cancer cell lines. Therefore, we first focused on determining the ef fects of PAK inhibitors on the panel of cancer cell lines listed in Table 1 using MTS based proliferation assays. MCF7 breast cancer, HT29 colon cell line and A549 lung cancer cell line are reported to be FTI sensitive cell line, while HeLa cervical and A375MM mel anoma cell line are reported to be resistant to FTIs.
The PAK inhibitor IPA3, which targets the Cdc42 mediated autophosphorylation of threonine 423 in group I PAK proteins, was used in these studies as it is highly specific. Proliferation tests were performed using a range of concentrations of IPA3 previously shown to affect the proliferation of different tumor cell lines. In prelim inary tests we also determined the toxic concentration of IPA3 in HeLa cells and A375MM cells. We observed that although HeLa cells are fairly resistant to this com pound, 48 h treatment with 20 uM IPA3 is toxic for this cell line. Based on this, a concentration of 2, 5, or 7 uM IPA3 was use in further studies. To perform these experiments, HeLa, A375MM, HT29, A549 and MCF7 cancer cell lines were left to at tach for 24 h in 96 well plates, treated with 5 uM FTI 277 or with 2, 5, or 7 uM IPA3 administrated alone, or with a combination of FTI 277 and IPA3.
The cells were then incubated for a further 48 h prior to data acquisi tion as described in Methods. We observed that A549 cells and MCF7 cells were sensitive to 5 uM FTI 277, while the other cell lines were not. All cell lines were sensitive to 7 uM IPA3, HeLa and MCF7 cells being the most sensitive, while A549, A375MM and HT29 cells show only moder ate sensitivity. The com bined use of 7 uM IPA3 and 5 uM FTI 277 resulted in the strongest inhibition of proliferation in all cell lines, A375MM cells being the most sensitive. However, it should be noted that the combin ation of 5 uM FTI 277 and 7 uM IPA3 did not substan tially change the basal sensitivity of HeLa and MCF7 cells observed using 7 uM IPA3 alone.
We concluded that inhibition of group I PAKs using IPA3 combined to FTI 277 treatment potently inhibits the proliferation of A375MM, A549 and HT29 cancer cell lines, Carfilzomib while IPA3 is highly effective in inhibiting the proliferation of HeLa and MCF7 cancer cell lines inde pendently of FTI treatment. To determine if the different proliferative ability of HeLa compared to A375MM cells in the presence of 5 uM FTI 277 and 7 uM IPA3 was due to selleck EPZ-5676 an increase in the number of apoptotic cells, we analyzed the percent age of cells that had fragmented nuclei using the ScanR analysis software.